Anticonvulsant properties of BIBP3226, a non-peptide selective antagonist at neuropeptide Y Y1 receptors

European Journal of Neuroscience

Volumn 10, Issue 2, 1998, Pages 757-759

  Gariboldi, Marco ^a   Conti, Mirco ^a   Cavaleri, Davide ^a   Samanin, Rosario ^a   Vezzani, Annamaria ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Dentate gyrus; EEG; Epilepsy; Hippocampus; Kainic acid

Indexed keywords

KAINIC ACID; NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEUROPEPTIDE Y1 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; COMPLEX PARTIAL SEIZURE; CONTROLLED STUDY; DENTATE GYRUS; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTICONVULSANTS; ARGININE; ELECTROENCEPHALOGRAPHY; HIPPOCAMPUS; INJECTIONS; LIMBIC SYSTEM; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROPEPTIDE Y; SEIZURES;

EID: 0031814389     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.1998.00061.x     Document Type: Article

References (21)

1. Brooks, P.A., Kelly, J.S., Allen, J.M., Smith, D.A.S. & Stone, T.W. (1987) Direct excitatory effects of neuropeptide Y (NPY) on rat hippocampal neurons in vitro. Brain Res., 408, 295-298.
2. DeLanerolle, N.C., Kim, J.H., Robbins, R.J. & Spencer, D.D. (1989) Hippocampal interneuron loss and plasticity in human temporal lobe epilepsy. Brain Res., 495, 387-395.
3. Drake, C.T., Terman, G.W., Simmons, M.L., Milner, T.A., Kunkel, D.D., Schwartzkroin, P.A. & Chavkin, C. (1994) Dynorphin opioids present in the dentate granule cells may function as retrograde inhibitory transmitters. J. Neurosci., 14, 3736-3750.
4. 3H]BIBP 3226. NeuroReport, 7, 901-904.
5. Erickson, J.C., Clegg, K.E. & Palmiter, R.D. (1996) Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature, 381, 415-418.
6. Frush, D.P. & McNamara, J.O. (1986) Evidence implicating dentate granule cells in wet dog shakes produced by kindling stimulations of entorhinal cortex. Exp. Neurol., 92, 102-113.
7. 34]Neuropeptide Y: a specific Y1 receptor agonist. Proc. Natl. Acad. Sci. USA, 87, 182-186.
8. Gobbi, M., Monhemius, R., Samanin, R., Mennini, T. & Vezzani, A. (1996) Cellular localization of neuropeptide Y receptors in the rat hippocampus: long-term effects of limbic seizures. NeuroReport, 7, 1475-1480.
9. Greber, S., Schwarzer, C. & Sperk, G. (1994) Neuropeptide Y inhibits potassium-stimulated glutamate release through Y2 receptors in rat hippocampal slices in vitro. Br. J. Pharmacol., 113, 737-740.
10. Klapstein, G.J. & Colmers, W.F. (1993) On the site of presynaptic inhibition by neuropeptide Y in the rat hippocampus in vitro. Hippocampus, 3, 103-112.
11. 1 receptors in kainic acid induced epilepsy in rats. Neurosci. Lett., 230, 1-4.
12. 1 receptors inhibit N-type calcium currents and reduce transient calcium increases in rat dentate granule cells. J. Neurosci., 16, 1422-1429.
13. Rizzi, M., Monno, A., Samanin, R. & Vezzani, A. (1993) Electrical kindling of the hippocampus is associated with functional activation of neuropeptide Y-containing neurons. Eur. J. Neurosci., 5, 1534-1538.
14. Rôder, C., Schwarzer, C., Vezzani, A., Gobbi, M., Mennini, T. & Sperk, G. (1996) Autoradiographic analysis of neuropeptide Y receptor binding sites in the rat hippocampus after kainic acid-induced limbic seizures. Neuroscience, 70, 47-55.
15. 1 receptor antagonist: BIBP3226. Eur. J. Pharmacol., 271, R11-R13.
16. Schwarzer, C., Sperk, G., Samanin, R., Rizzi, M., Gariboldi, M. & Vezzani, A. (1996) Neuropeptides-immunoreactivity and their mRNA expression in kindling: functional implications for limbic epileptogenesis. Brain Res. Rev., 22, 27-50.
17. Simmons, M.L., Terman, G.W., Gibbs, S.M. & Chavkin, C. (1995) L-type calcium channels mediate dynorphin neuropeptide release from dendrites but not axons of hippocampal granule cells. Neuron, 14, 1265-1272.
18. Vezzani, A., Civenni, G., Rizzi, M., Galli, A., Barrios, M. & Samanin, R. (1994) Enhanced neuropeptide Y release in the hippocampus is associated with chronic seizure susceptibility in kainic acid treated rats. Brain Res., 660, 138-143.
19. Vezzani, A., Serafini, R., Stasi, M.A., Vigano', G., Rizzi, M. & Samanin, R. (1991) A peptidase-resistant cyclic octapeptide analogue of somatostatin (SMS 201-995) modulates seizures induced by quinolinic and kainic acids differently in the rat hippocampus. Neuropharmacol., 30, 345-352.
20. Wieland, H.A., Willim, K.D., Entezeroth, M., Wienen, W., Rudolf, K., Eberlein, W., Engel, W. & Doods, H.N. (1995) Subtype selectivity and antagonistic profile of the nonpeptide Y1 receptor antagonist BIBP3226. J. Pharmacol. Exp. Ther., 275, 143-149.
21. Woldbye, D.P.D., Larsen, P.J., Mikkelsen, J.D., Klemp, K., Madsen, T.M. & Bolwig, T.G. (1997) Powerful inhibition of kainic acid seizures by neuropeptide Y via Y5-like receptors. Nature Med., 7, 761-764.